Your browser doesn't support javascript.
loading
DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival.
Wu, Zhichao; Lopes Abath Neto, Osorio; Bale, Tejus A; Benhamida, Jamal; Mata, Douglas; Turakulov, Rust; Abdullaev, Zied; Marker, Daniel; Ketchum, Courtney; Chung, Hye-Jung; Giannini, Caterina; Quezado, Martha; Pratt, Drew; Aldape, Kenneth.
Afiliação
  • Wu Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Lopes Abath Neto O; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Bale TA; Department of Pathology, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.
  • Benhamida J; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Mata D; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Turakulov R; Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
  • Abdullaev Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Marker D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Ketchum C; Department of Pathology, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.
  • Chung HJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Giannini C; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Quezado M; Department of Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.
  • Pratt D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. drew.pratt@nih.gov.
Acta Neuropathol ; 144(1): 155-157, 2022 07.
Article em En | MEDLINE | ID: mdl-35567606

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Acta Neuropathol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Acta Neuropathol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos